Download FREE Report Sample
Download Free sampleCelecoxib, sold under the brand name Celebrex among others, is a COX-2 selective nonsteroidal anti-inflammatory drug (NSAID). It is used to treat the pain and inflammation in osteoarthritis, acute pain in adults, rheumatoid arthritis, ankylosing spondylitis, painful menstruation, and juvenile rheumatoid arthritis. It may also be used to decrease the risk of colorectal adenomas in people with familial adenomatous polyposis. It is taken by mouth. Benefits are typically seen within an hour.
Celecoxib Capsule Market contains market size and forecasts of Celecoxib Capsule in Global, including the following market information:
Global Celecoxib Capsule Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Celecoxib Capsule market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
50mg Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Celecoxib Capsule include Pfizer, Teva, Mylan, Apotex, Lupin and HENGRUI MEDICINE, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Celecoxib Capsule companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Celecoxib Capsule Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Celecoxib Capsule Market Segment Percentages, by Type, 2021 (%)
50mg
100mg
200mg
400mg
Global Celecoxib Capsule Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Celecoxib Capsule Market Segment Percentages, by Application, 2021 (%)
Rheumatoid Arthritis
Osteoarthritis
Acute Pain
Musculoskeletal Pain
Others
Global Celecoxib Capsule Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Celecoxib Capsule Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Celecoxib Capsule revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Celecoxib Capsule revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Teva
Mylan
Apotex
Lupin
HENGRUI MEDICINE
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
